vs
Ouster, Inc.（OUST）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Ouster, Inc.的1.2倍（$75.5M vs $62.2M），Ouster, Inc.同比增速更快（106.6% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-37.2M），过去两年Ouster, Inc.的营收复合增速更高（54.8% vs 31.3%）
Ouster, Inc.是总部位于美国加利福尼亚州旧金山的激光雷达技术企业，主打高分辨率数字化3D激光雷达传感器，产品广泛应用于自动驾驶车辆、工业自动化、机器人、无人机、地图测绘、国防及安防等领域。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
OUST vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$62.2M
营收增速更快
OUST
高出78.9%
27.7%
自由现金流更多
PBYI
多$51.6M
$-37.2M
两年增速更快
OUST
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.2M | $75.5M |
| 净利润 | — | — |
| 毛利率 | 60.2% | 69.3% |
| 营业利润率 | 1.5% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 106.6% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.10 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OUSTPBYI
| Q4 25 | $62.2M | $75.5M | ||
| Q3 25 | $39.5M | $54.5M | ||
| Q2 25 | $35.0M | $52.4M | ||
| Q1 25 | $32.6M | $46.0M | ||
| Q4 24 | $30.1M | $59.1M | ||
| Q3 24 | $28.1M | $80.5M | ||
| Q2 24 | $27.0M | $47.1M | ||
| Q1 24 | $25.9M | $43.8M |
净利润OUSTPBYI
| Q4 25 | — | — | ||
| Q3 25 | $-21.7M | $8.8M | ||
| Q2 25 | $-20.6M | $5.9M | ||
| Q1 25 | $-22.0M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-25.6M | $20.3M | ||
| Q2 24 | $-23.9M | $-4.5M | ||
| Q1 24 | $-23.8M | $-4.8M |
毛利率OUSTPBYI
| Q4 25 | 60.2% | 69.3% | ||
| Q3 25 | 42.1% | 77.7% | ||
| Q2 25 | 45.2% | 76.5% | ||
| Q1 25 | 41.3% | 77.1% | ||
| Q4 24 | 43.8% | 76.4% | ||
| Q3 24 | 38.3% | 63.9% | ||
| Q2 24 | 33.7% | 77.4% | ||
| Q1 24 | 28.6% | 75.5% |
营业利润率OUSTPBYI
| Q4 25 | 1.5% | 22.7% | ||
| Q3 25 | -61.4% | 17.6% | ||
| Q2 25 | -76.5% | 12.7% | ||
| Q1 25 | -73.0% | 8.7% | ||
| Q4 24 | -85.1% | 22.6% | ||
| Q3 24 | -98.0% | 27.4% | ||
| Q2 24 | -93.6% | -4.6% | ||
| Q1 24 | -99.5% | -5.3% |
净利率OUSTPBYI
| Q4 25 | — | — | ||
| Q3 25 | -55.0% | 16.2% | ||
| Q2 25 | -58.8% | 11.2% | ||
| Q1 25 | -67.5% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -91.1% | 25.2% | ||
| Q2 24 | -88.4% | -9.6% | ||
| Q1 24 | -91.9% | -11.0% |
每股收益（稀释后）OUSTPBYI
| Q4 25 | $0.10 | $0.26 | ||
| Q3 25 | $-0.37 | $0.17 | ||
| Q2 25 | $-0.38 | $0.12 | ||
| Q1 25 | $-0.42 | $0.06 | ||
| Q4 24 | $-0.46 | $0.40 | ||
| Q3 24 | $-0.54 | $0.41 | ||
| Q2 24 | $-0.53 | $-0.09 | ||
| Q1 24 | $-0.55 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $261.7M | $130.3M |
| 总资产 | $349.5M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资OUSTPBYI
| Q4 25 | $208.6M | $97.5M | ||
| Q3 25 | $244.5M | $94.4M | ||
| Q2 25 | $226.5M | $96.0M | ||
| Q1 25 | $168.2M | $93.2M | ||
| Q4 24 | $172.0M | $101.0M | ||
| Q3 24 | $151.4M | $96.7M | ||
| Q2 24 | $184.2M | $96.8M | ||
| Q1 24 | $187.8M | $107.2M |
总债务OUSTPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益OUSTPBYI
| Q4 25 | $261.7M | $130.3M | ||
| Q3 25 | $247.4M | $115.3M | ||
| Q2 25 | $221.0M | $104.7M | ||
| Q1 25 | $167.9M | $97.1M | ||
| Q4 24 | $180.9M | $92.1M | ||
| Q3 24 | $171.7M | $71.1M | ||
| Q2 24 | $170.6M | $48.5M | ||
| Q1 24 | $167.2M | $51.0M |
总资产OUSTPBYI
| Q4 25 | $349.5M | $216.3M | ||
| Q3 25 | $353.8M | $202.9M | ||
| Q2 25 | $321.8M | $194.9M | ||
| Q1 25 | $268.6M | $196.2M | ||
| Q4 24 | $276.1M | $213.3M | ||
| Q3 24 | $255.2M | $220.7M | ||
| Q2 24 | $309.9M | $205.0M | ||
| Q1 24 | $317.7M | $214.1M |
负债/权益比OUSTPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-37.2M | $14.4M |
| 自由现金流率自由现金流/营收 | -59.8% | 19.1% |
| 资本支出强度资本支出/营收 | 35.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-64.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流OUSTPBYI
| Q4 25 | $-15.4M | $14.4M | ||
| Q3 25 | $-18.3M | $9.7M | ||
| Q2 25 | $-1.3M | $14.1M | ||
| Q1 25 | $-4.9M | $3.6M | ||
| Q4 24 | $-2.6M | $15.6M | ||
| Q3 24 | $-3.8M | $11.0M | ||
| Q2 24 | $-21.6M | $1.0M | ||
| Q1 24 | $-5.7M | $11.2M |
自由现金流OUSTPBYI
| Q4 25 | $-37.2M | $14.4M | ||
| Q3 25 | $-20.0M | $9.7M | ||
| Q2 25 | $-2.2M | $14.1M | ||
| Q1 25 | $-5.4M | $3.6M | ||
| Q4 24 | $-4.0M | $15.6M | ||
| Q3 24 | $-4.3M | $11.0M | ||
| Q2 24 | $-22.0M | $1.0M | ||
| Q1 24 | $-7.1M | — |
自由现金流率OUSTPBYI
| Q4 25 | -59.8% | 19.1% | ||
| Q3 25 | -50.7% | 17.7% | ||
| Q2 25 | -6.3% | 26.8% | ||
| Q1 25 | -16.6% | 7.7% | ||
| Q4 24 | -13.3% | 26.4% | ||
| Q3 24 | -15.4% | 13.7% | ||
| Q2 24 | -81.5% | 2.1% | ||
| Q1 24 | -27.4% | — |
资本支出强度OUSTPBYI
| Q4 25 | 35.0% | 0.0% | ||
| Q3 25 | 4.3% | 0.0% | ||
| Q2 25 | 2.5% | 0.0% | ||
| Q1 25 | 1.7% | 0.1% | ||
| Q4 24 | 4.8% | 0.0% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 1.3% | 0.0% | ||
| Q1 24 | 5.3% | 0.0% |
现金转化率OUSTPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
